David York Norton
Independent DirectorMr. David York Norton is an Independent Director at COMPASS Pathways plc since May 2018, served as its Chairman since March 29, 2024 until September 03, 2024 and served as its Lead Independent Director until 2024. He serves as Member of Strategic Advisory Board at Forepont Capital Partners. He served as an Independent board member at Forepont Capital Partners. He serves as Senior Advisor to Tapestry Networks Boston/London. During his career at Johnson & Johnson, Mr. Norton has held a wide range of management positions of increasing responsibility in Europe, Australia, New Zealand and the United States and serves as President of the Janssen Pharmaceuticals business in the U.S. He has extensive experience in the biopharmaceutical industry. He has extensive commercial experience. Mr. Norton served as an Interim Chief Executive Officer of Savient Pharmaceuticals, Inc. from February 1, 2012 to July 2012. He served as Group Chairman of Global Pharmaceuticals for Johnson & Johnson from May 2009 to September 2011 where he led and developed the business' strategic growth agenda, including the strategy for licensing, acquisitions and divestments and ensuring alignment with the global strategic functions, research and development and commercial organizations. At Johnson & Johnson, he served as Company Group Chairman, Worldwide Commercial and Operations for the CNS, Internal Medicine and Virology franchise and also served as Company Group Chairman for the pharmaceutical businesses in Europe, Middle East and Africa from 2004 to 2006, as well as for North America and Canada. He began his career there as a Product Manager for Janssen Pharmaceutica in Australia and advanced to international product manager at Janssen's Belgium headquarters where he later served as managing director of Janssen Australia and New Zealand. He served as Board Treasurer at Pharmaceutical Research and Manufacturers of America. He served as Chairman at VIVUS, Inc since September 12, 2014. He served as the Chairman of INC Research Holdings, Inc. since May 31, 2016 until August 2017. He had been a Director of VIVUS, Inc. since July 19, 2013 until December 2020. He served as a Director at INC Research Holdings, Inc. since February 3, 2015 until August 3, 2017. He was responsible for leading and developing the company's strategic growth agenda, including the strategy for licensing, acquisitions and divestments and ensuring alignment with the global strategic functions, R&D and the commercial organizations. Mr. Norton began his Johnson & Johnson career in 1979 as a Product Manager for the company's affiliate Janssen Pharmaceutica in Australia and during his tenure served a number of positions, including Company Group Chairman, Worldwide Commercial and Operations, CNS/Internal Medicine franchise from 2006 to 2009; Company Group Chairman, Pharmaceutical Group, Europe, the Middle East and Africa; and Company Group Chairman, Pharmaceuticals Group, North America from 2003 to 2004. He serves on the board of TB Alliance. He had been a Director at Mallinckrodt Public Limited Company since September 20, 2017 until June 2022. He is a Director at Forepont Capital, LLC since October 2019. He served as a Director of Savient Pharmaceuticals, Inc. since September 6, 2011. He served as a Member of the Board of Directors at the Pharmaceutical Research and Manufacturers of America (PhRMA). He was a Board member of the Alliance for Aging Research until December 2019. He serves as the Chairman of the Board of Directors of the American Foundation for Suicide Prevention. Mr. Norton obtained his Marketing degree from the College of Distributive Trades, London. Mr. Norton holds degree in Computer Programming Technology from Control Data Institute in Sydney, Australia.
Positions
- Company NameCOMPASS Pathways plcStock CodeCMPSPositionIndependent DirectorColleagues
- KKKabir Kumar NathCEO & Executive Director
- GSGino SantiniIndependent Chairman
- TLTeri LoxamChief Financial Officer
- GGGuy GoodwinChief Medical Officer
- SDStephen D. SchultzSenior Vice President of Investor Relations
- KBKelley BoucherChief People Officer
- DKDaphne KarydasIndependent Director
- RDRobert Dwyer McQuadeIndependent Non Executive Director
